Staskin, D R <br/><br/>
Trospium chloride once-daily extended release is effective and well tolerated for the treatment of overactive bladder syndrome: an integrated analysis of two randomised, phase III trials.  [electronic resource] 

 -  International journal of clinical practice  Dec 2009 
 - 1715-23 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1742-1241 
<br/><br/><label>Standard No.: </label>10.1111/j.1742-1241.2009.02189.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Benzilates<br/>Delayed-Action Preparations<br/>Double-Blind Method<br/>Drug Administration Schedule<br/>Female<br/>Humans<br/>Male<br/>Middle Aged<br/>Muscarinic Antagonists--administration & dosage<br/>Nortropanes--administration & dosage<br/>Treatment Outcome<br/>Urinary Bladder, Overactive--drug therapy